420 / 1609
•
24 patients with 32 recurrent keloids with two or
more failed treatment modalities, 3 patients had been
previously treated with EBRT
•
with perioperative HDR;
3 x 6 Gy to 5 mm
total
TREATMENT: RECURRENT KELOIDS
dose of 18 Gy within 36 hours after the resection.
•
Disappearance of pain and pruritus was noticed in all
patients (19).
•
FU 29.4 m, 2 keloid recurrences and 2 mildly
hypertrophied scars. Local control:
94%.
•
Pigmentary abnormalities in 3 patients,
•
mild delay in the wound-healing process, 6 pat.
Jiang P, Baumann R, Dunst J et al. Perioperative Interstitial High-Dose-Rate Brachytherapy
for the Treatment of Recurrent Keloids: Feasibility and Early Results.IJROBP 2016; 94:532-6.